Every 8-K that GP-Act III Acquisition Corp (GPAT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow GPAT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GPAT filings page.
GP-Act III Acquisition Corp. obtained shareholder approval to extend the deadline to complete a business combination from May 13, 2026 to November 13, 2026 and to amend its trust agreement accordingly. This keeps the SPAC active for several more months instead of triggering a wind-up on the original date.
To support the extension, the sponsor entered into Non-Redemption Agreements covering 8,074,387 Class A ordinary shares, agreeing to transfer 403,720 Class A shares to participating investors after a successful business combination if they do not redeem and vote for the changes. At the extraordinary general meeting, 30,864,730 shares, or 85.88% of those entitled to vote, were represented, and the Extension Amendment and Trust Amendment each passed with 23,799,592 votes for and 7,065,138 against.
In connection with the extension vote, holders of 19,776,272 Class A ordinary shares elected to redeem at approximately $10.89 per share, for an aggregate of about $215.4 million, leaving approximately $97.8 million in the trust account to fund a future business combination.
GP-Act III Acquisition Corp. entered into non-redemption agreements with certain shareholders to support extending its deadline to complete a business combination. Investors agreed not to redeem and to vote in favor of extending the termination and trust liquidation dates from May 13, 2026 to November 13, 2026 for 8,074,387 Class A shares. In return, the sponsor will transfer an aggregate 403,720 Class A shares to these investors after a successful business combination, if specified voting and non-redemption conditions are met. These agreements are intended to increase both the chances of approval for the extension proposals and the cash remaining in the SPAC’s trust account.
GP-Act III Acquisition Corp. outlines plans to enter into non-redemption agreements with one or more third-party shareholders to support extending its deadline to complete a business combination. The proposed Extension Amendment and Trust Amendment would move the current May 13, 2026 termination dates to November 13, 2026.
In these non-redemption agreements, shareholders would agree not to redeem specified Class A ordinary shares and to vote in favor of the extension proposals. In return, GP-Act III Sponsor LLC anticipates transferring a negotiated number of Class A ordinary shares to these investors after the initial business combination closes.
GP-Act III Acquisition Corp. held an extraordinary general meeting on May 6, 2026 and shareholders approved adjourning the meeting to allow more time to solicit proxies on two key extension proposals. The adjournment proposal passed with 21,424,593 votes for, 8,064,137 against and 1,000 abstentions.
The adjourned meeting is scheduled for May 12, 2026, when shareholders will vote on extending the deadline to complete a business combination and to liquidate the SPAC’s trust account from May 13, 2026 to November 13, 2026. Holders who previously elected to redeem their Class A shares are permitted to reverse those redemption requests by contacting the transfer agent by 9:00 a.m. Eastern Time on May 12, 2026.
GP-Act III Acquisition Corp. converted all of its Class B “Founder Shares” into Class A ordinary shares on a one-for-one basis. A total of 7,187,500 Class B shares were cancelled and 7,187,500 Class A shares were issued to the sponsor and three independent directors.
After this conversion, the company has approximately 35,937,500 Class A ordinary shares outstanding and no Class B shares. Because shareholder voting power is based on combined holdings of both classes, the company states that the conversion does not change voting outcomes for shareholder approvals.
GP-Act III Acquisition Corp. adjourned its extraordinary general meeting held on April 29, 2026 after shareholders approved an adjournment proposal to allow more time to solicit proxies. The meeting will reconvene on May 6, 2026 to vote on extending its business combination deadline and related trust agreement from May 13, 2026 to November 13, 2026.
Of 35,937,500 ordinary shares outstanding on the March 24, 2026 record date, 81.67% were represented, and the adjournment proposal received 21,313,393 votes for, 8,034,735 against and 1,000 abstentions. Shareholders who previously elected to redeem their public Class A shares may reverse their redemption requests by contacting the transfer agent by 9:00 a.m. Eastern Time on May 6, 2026.